Metabolic syndrome (MetS) is considered a metabolic disorder that has been steadily
increasing globally and seems to parallel the increasing prevalence of obesity. It consists of …

Background & Objective: Metabolic syndrome (MetS) is an interconnected group of
physiological, biochemical, clinical and metabolic factors that directly increase the risk of …

Abstract Cardio Metabolic Syndrome (CMS), also known as insulin resistance syndrome or
metabolic syndrome X, is a combination of metabolic disorders or risk factors that essentially …

Metabolic Syndrome (MetS) is a cluster of risk factors that, taken alone or synergically, are
independent predictors of type 2 diabetes and cardiovascular disease (CVD), which are …

Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide,
especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia …

Metabolic syndrome (MetS) is characterized by accumulation of visceral fat associated with
the clustering of metabolic and pathophysiological cardiovascular risk factors: impaired …

Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …

Background and Aims: Metabolic syndrome is a multifactorial pathophysiological process
with complicated homeostatic disorders that arise from various systematic metabolic defects …

The metabolic syndrome (MetS), first introduced by Haller in 1975, was sometimes also
known as insulin resistance syndrome, syndrome X, and plurimetabolic syndrome. In 1989 …

The prevalence of MetS worldwide is high and continuously increasing. Following the
National Cholesterol Education Program Adult Treatment Panel III definition, 6 the …